Cigna Corp (NYSE:CI)’s stock price traded up 1.7% during mid-day trading on Friday . The company traded as high as $185.77 and last traded at $178.32, 179,389 shares changed hands during trading. A decline of 88% from the average session volume of 1,469,060 shares. The stock had previously closed at $175.34.
A number of research analysts have recently issued reports on the company. Goldman Sachs Group raised Puxin from a “neutral” rating to a “buy” rating and upped their price target for the company from $51.00 to $56.00 in a report on Friday, May 3rd. Barclays set a $24.00 price target on Tenet Healthcare and gave the company a “hold” rating in a report on Wednesday, April 17th. Citigroup raised Atara Biotherapeutics from a “sell” rating to a “neutral” rating and upped their price target for the company from $23.00 to $24.00 in a report on Monday, June 3rd. Zacks Investment Research raised HB Fuller from a “sell” rating to a “hold” rating in a report on Tuesday, June 11th. Finally, UBS Group set a $36.00 price target on Halliburton and gave the company a “buy” rating in a report on Tuesday, April 23rd. One research analyst has rated the stock with a sell rating, three have given a hold rating and fourteen have issued a buy rating to the company. The company has a consensus rating of “Buy” and a consensus target price of $217.40.
The stock has a market cap of $60.91 billion, a P/E ratio of 12.60, a PEG ratio of 0.79 and a beta of 0.71. The company has a debt-to-equity ratio of 0.89, a quick ratio of 0.70 and a current ratio of 0.70. The stock’s 50-day simple moving average is $157.65.
Cigna (NYSE:CI) last posted its quarterly earnings data on Thursday, May 2nd. The health services provider reported $3.90 EPS for the quarter, beating analysts’ consensus estimates of $3.74 by $0.16. The company had revenue of $33.43 billion during the quarter, compared to analysts’ expectations of $32.79 billion. Cigna had a return on equity of 14.23% and a net margin of 4.11%. Cigna’s revenue for the quarter was up 192.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.11 earnings per share. Analysts forecast that Cigna Corp will post 16.56 EPS for the current fiscal year.
Institutional investors and hedge funds have recently modified their holdings of the business. FMR LLC boosted its stake in shares of Cigna by 21.6% in the first quarter. FMR LLC now owns 12,229,261 shares of the health services provider’s stock worth $1,966,710,000 after acquiring an additional 2,171,463 shares during the period. Geode Capital Management LLC boosted its stake in shares of Cigna by 61.3% in the fourth quarter. Geode Capital Management LLC now owns 4,939,173 shares of the health services provider’s stock worth $936,405,000 after acquiring an additional 1,876,556 shares during the period. Boston Partners boosted its stake in shares of Cigna by 34.7% in the first quarter. Boston Partners now owns 4,895,908 shares of the health services provider’s stock worth $787,360,000 after acquiring an additional 1,261,911 shares during the period. Veritas Asset Management LLP boosted its stake in shares of Cigna by 3.3% in the first quarter. Veritas Asset Management LLP now owns 4,605,129 shares of the health services provider’s stock worth $740,597,000 after acquiring an additional 146,675 shares during the period. Finally, Barrow Hanley Mewhinney & Strauss LLC boosted its stake in shares of Cigna by 179.2% in the fourth quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 4,456,861 shares of the health services provider’s stock worth $846,447,000 after acquiring an additional 2,860,291 shares during the period. Institutional investors and hedge funds own 88.18% of the company’s stock.
Cigna Company Profile (NYSE:CI)
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Story: What is a Derivative?
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.